港股異動 | 理文造紙(2314.HK)連續3日上漲 績後獲投行持續唱好
格隆匯8月6日丨理文造紙(2314.HK)續升超4%,連續3日上漲逾15%。報6.6港元創近一個月新高且走出V型反轉行情,總市值為286億港元。理文造紙4日午間公佈,中期純利升44.9%至19.36億港元,中期息15港仙。大和將公司目標價由6.3港元升11%至7港元,上調2021-22年的調整後淨利潤預測12%-19%,以反映更高的產品和瓦楞紙箱(OCC)價格;花旗指,理文造紙上半年股東應占純利略高於19億港元的預測。因此,將2021年至2023財年的利潤預測提高了4%至6%,因上調箱板紙的利潤率預測。目標價由8.4港元升至8.6港元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.